BTK and systemic sclerosis: In addition, adoptive transfer of topo I-APC+ topo I-PE+ CD19+ cells from the topo I-induced SSc model mice treated with the BTK inhibitor failed to induce skin and lung fibrosis in non-immunized WT mice (Figure 7E).